Published in Peptides on August 06, 1992
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci U S A (1995) 1.58
Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol (1993) 0.87
Behavioral effects of peripheral corticotropin-releasing factor during maternal separation may be mediated by proinflammatory activity. Psychoneuroendocrinology (2011) 0.81
Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Dev Neurosci (1999) 0.81
Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal. Br J Pharmacol (2014) 0.80
Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine. Br J Pharmacol (1999) 0.78
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A (1985) 4.60
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature (1984) 4.27
Common precursor to corticotropins and endorphins. Proc Natl Acad Sci U S A (1977) 3.99
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (1982) 3.10
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (1977) 2.68
Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46
Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature (1986) 2.37
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
[Endorphins, hypothalamic and neurohypophysial peptides with morphinomimetic activity: isolation and molecular structure of alpha-endorphin]. C R Acad Sci Hebd Seances Acad Sci D (1976) 2.22
Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia (2001) 2.18
Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature (1986) 2.17
Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun (1987) 2.08
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature (1993) 2.03
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc Natl Acad Sci U S A (1978) 1.98
Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1988) 1.87
Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. Proc Natl Acad Sci U S A (1976) 1.80
beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proc Natl Acad Sci U S A (1976) 1.79
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proc Natl Acad Sci U S A (1977) 1.74
Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (1995) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Somatostatin. Recent Prog Horm Res (1975) 1.67
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A (1982) 1.66
Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab (1982) 1.64
Role of the central melanocortin system in cachexia. Cancer Res (2001) 1.60
Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A (1983) 1.57
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A (1972) 1.57
Radioimmunoassays for alpha-endorphin and beta-endorphin. Biochem Biophys Res Commun (1977) 1.55
Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature (1977) 1.54
Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci U S A (1985) 1.54
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science (1976) 1.50
Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem (1993) 1.44
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
Antibodies to peptide determinants in transforming growth factor beta and their applications. Biochemistry (1988) 1.43
Multiple influences of a heparin-binding growth factor on neuronal development. J Cell Biol (1987) 1.40
Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. Life Sci (1977) 1.37
Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. Proc Natl Acad Sci U S A (1977) 1.36
Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res (1991) 1.36
Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res (1986) 1.35
Solid phase synthesis of somatostatin-28. Biochem Biophys Res Commun (1980) 1.34
Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci U S A (1988) 1.33
Orientation changes in myosin regulatory light chains following photorelease of ATP in skinned muscle fibers. Biophys J (1996) 1.32
Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochem Biophys Res Commun (1985) 1.31
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci U S A (1973) 1.31
Compromised GCF total antioxidant capacity in periodontitis: cause or effect? J Clin Periodontol (2006) 1.30
RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci U S A (1984) 1.30
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas. Oncogene Res (1989) 1.30
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci U S A (1987) 1.29
Leucosulfakinin, a sulfated insect neuropeptide with homology to gastrin and cholecystokinin. Science (1986) 1.27
Biologic and immunologic activities and applications of somatostatin analogs. Metabolism (1978) 1.23
Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature (1981) 1.23
Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs. Proc Natl Acad Sci U S A (1976) 1.22
Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore) (1999) 1.20
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc Natl Acad Sci U S A (1982) 1.19
Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc Natl Acad Sci U S A (1980) 1.18
A new prosomatostatin-derived peptide reveals a pattern for prohormone cleavage at monobasic sites. Science (1987) 1.17
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol (1998) 1.16
High-molecular-weight immunoreactive beta-endorphin in extracts of human placenta is a fragment of immunoglobulin G. Science (1980) 1.16
The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology (1984) 1.15
Immunohistochemical detection of growth hormone-releasing factor in brain. Nature (1983) 1.15
Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene (1999) 1.13
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D (1972) 1.13
Determinants of plasma glucose level and diabetic status in a northern Canadian Indian population. CMAJ (1990) 1.11
Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin. Endocrinology (1991) 1.11
Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun (1988) 1.11
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol (1997) 1.09
Anatomic and phylogenetic distribution of somatostatin. Metabolism (1976) 1.08
Opioid activities of fragments of beta-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin. Eur J Pharmacol (1979) 1.08
Isolation of an amino terminal extended form of basic fibroblast growth factor. Biochem Biophys Res Commun (1986) 1.07
Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A (1984) 1.06
Sensory integration in the hydrodynamic world of rainbow trout. Proc Biol Sci (2003) 1.06
Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience (1999) 1.06
Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology (1992) 1.06
Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro. Regul Pept (1985) 1.05
Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology (1990) 1.04
Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther (2000) 1.04
Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. J Clin Endocrinol Metab (1978) 1.04
Pro-adrenocorticotropin/endorphin-derived peptides: coordinate action on adrenal steroidogenesis. Science (1980) 1.03
Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol Endocrinol (1987) 1.03
Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol (1989) 1.02
Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor. Regul Pept (1985) 1.02
Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem (1991) 1.02
Follistatin binds to both activin and inhibin through the common subunit. Endocrinology (1991) 1.01
Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. Biochem Biophys Res Commun (1982) 1.01
Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochem Biophys Res Commun (1982) 1.01
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. Proc Natl Acad Sci U S A (1998) 1.01
Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med (1991) 1.00
Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology (1998) 0.99
A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochem Biophys Res Commun (1986) 0.99
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun (1983) 0.99
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun (1983) 0.99
Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency. J Immunol (2000) 0.99
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia (1997) 0.99
125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Mol Pharmacol (1996) 0.99
Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. Immunol Lett (1989) 0.98
The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone. Biochem Biophys Res Commun (1973) 0.98
Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol Endocrinol (1987) 0.98
Analogs of luteinizing hormone releasing factor (LRF). Synthesis and biological activity of ((Nalpha-Me)Leu-7)LRF and (D-Ala-6,(Nalpha-Me)Leu-7)LRF. Biochem Biophys Res Commun (1975) 0.98